Prospective phase 2 clinical trail on Tourette's Syndrome
This study is focusing on Tourette's Syndrome using medicines that are aligned with OnTracka's core focus for completing clinical trials.
Study area
Tourette's Syndrome
What are the existing options for Tourette's Syndrome?
Tourette's Syndrome occurs in at least 1% of the population worldwide.
Existing treatment options
Fluphenazine, haloperidol (Haldol), risperidone (Risperdal) and pimozide (Orap).
Who is the study for?
If you are a young person or a carer of a young person with Tourette's Syndrome, contact us to see if you are eligible for the study.
What will patients be taking in this study?
Further details will be provided on the basis of you or a loved one meeting the eligibility criteria for the study.
Why would you join?
Further details will be provided on the basis of you or a loved one meeting the eligibility criteria for the study.
Australia
LOCATION
NA
TOTAL PATIENTS
Under a year
DURATION